MENU

Agenda

  • Introduction & Opening Remarks
    OCT 08, 2025 8:05 AM PDT

    Introduction & Opening Remarks

    Dr. Ray Chen
    President of GenScript Life Science Group
  • Old Friends & New Partners: AI-driven Models and Agents for Genome and Cell Engineering
    OCT 08, 2025 8:20 AM PDT

    Old Friends & New Partners: AI-driven Models and Agents for Genome and Cell Engineering

    Dr. Le Cong
    Assistant Professor, Pathology and Genetics at Stanford University
    BIOGRAPHY
  • From Single Cells to Smart Solutions: AI-Powered Platforms Transforming Antibody Discovery and Microbial Screening
    OCT 08, 2025 9:00 AM PDT

    From Single Cells to Smart Solutions: AI-Powered Platforms Transforming Antibody Discovery and Microbial Screening

    Bingqing Shen, PhD
    Chief Product Officer, Bioelectronica
    BIOGRAPHY
  • COMPACT: A De Novo Protein Platform for Smarter Therapeutic
    OCT 08, 2025 10:00 AM PDT

    COMPACT: A De Novo Protein Platform for Smarter Therapeutic

    Dr. Ori Hassin, M.D, PhD
    Chief Scientific Officer and Co-founder of ZipBio
    BIOGRAPHY
  • Burn Fat, Not Muscle: Gene Silencing to Reprogram Fat, Boost Energy Expenditure, and Treat Obesity
    OCT 08, 2025 10:40 AM PDT

    Burn Fat, Not Muscle: Gene Silencing to Reprogram Fat, Boost Energy Expenditure, and Treat Obesity

    Dr. Raj Reddy
    President and CEO of Canary Cure
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE
  • AI Enabled Systems Level Approach to Solid Tumors
    OCT 08, 2025 11:40 AM PDT

    AI Enabled Systems Level Approach to Solid Tumors

    T. S. Karin Eisinger, PhD
    CEO and Co-Founder, SyzOnc Inc
    BIOGRAPHY
  • AI-Driven mRNA Drug Design and Application
    OCT 08, 2025 12:20 PM PDT

    AI-Driven mRNA Drug Design and Application

    Liang Zhang, PhD
    Hangzhou Institute of Medicine
    BIOGRAPHY
  • Closing Remarks
    OCT 08, 2025 1:00 PM PDT

    Closing Remarks

    Aylin Kosova Bilgin
    Chief Marketing Officer, GenScript
OCT 8, 2025 Opens: 11:00 AM EDT

2025 GenScript Virtual Summit: Scripting the Future

The 2025 GenScript Virtual Summit—formerly the Gene and Cell Engineering Summit—serves as a leading international forum for scientists, biotech innovators, and pharmaceutical leaders to examine cutting-edge advances shaping the next generation of therapeutics. Over the past years, the Summit has convened thousands of researchers across academia and industry, providing a platform for scientific exchange and cross-disciplinary collaboration.

Aligned with GenScript’s renewed branding vision—“Scripting Possibilities”—this year’s Summit reflects the translational reality of modern biopharmaceutical R&D. By expanding its scope beyond gene and cell engineering to include therapeutic antibody discovery and the application of AI-driven methodologies, the Summit emphasizes the convergence of technologies that are redefining discovery pipelines, accelerating development timelines, and transforming clinical translation.

2025 Focus Themes

1. AI-Driven Drug Discovery: from in-silico hit identification and molecular design to clinical candidate optimization

2. Next-Generation Gene & Cell Engineering: CRISPR 3.0, precision base-editing systems, in-vivo delivery modalities

3. Therapeutic Antibody Innovation: synthetic library platforms, de novo protein design, and multi-specific antibody formats

4. Translational & Regulatory Frontiers: IND-enabling data strategies, advanced CMC considerations, and global regulatory harmonization

Learning Objectives:

  • Explore cutting-edge applications of CRISPR, base editing, and cell therapy in next-gen biotherapeutics.

  • Master AI/ML integration into antibody design, gene synthesis, and preclinical development workflows.

  • Build cross-disciplinary collaborations to accelerate translational research from bench to clinic.


Speakers
  • Dr. Le Cong

    Assistant Professor, Pathology and Genetics at Stanford University
    BIOGRAPHY
  • T. S. Karin Eisinger, PhD

    CEO and Co-Founder, SyzOnc Inc
    BIOGRAPHY
  • Dr. Ori Hassin, M.D, PhD

    Chief Scientific Officer and Co-founder of ZipBio
    BIOGRAPHY
  • Dr. Raj Reddy

    President and CEO of Canary Cure
    BIOGRAPHY
  • Bingqing Shen, PhD

    Chief Product Officer, Bioelectronica
    BIOGRAPHY
  • Liang Zhang, PhD

    Hangzhou Institute of Medicine
    BIOGRAPHY

You May Also Like

Speakers


  • Dr. Le Cong

    Dr. Le Cong

    Assistant Professor, Pathology and Genetics at Stanford University

    BIOGRAPHY
  • T. S. Karin Eisinger, PhD

    T. S. Karin Eisinger, PhD

    CEO and Co-Founder, SyzOnc Inc

    BIOGRAPHY
  • Dr. Ori Hassin, M.D, PhD

    Dr. Ori Hassin, M.D, PhD

    Chief Scientific Officer and Co-founder of ZipBio

    BIOGRAPHY
  • Dr. Raj Reddy

    Dr. Raj Reddy

    President and CEO of Canary Cure

    BIOGRAPHY
  • Bingqing Shen, PhD

    Bingqing Shen, PhD

    Chief Product Officer, Bioelectronica

    BIOGRAPHY
  • Liang Zhang, PhD

    Liang Zhang, PhD

    Hangzhou Institute of Medicine

    BIOGRAPHY

Continuing Education Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


Help

Loading Comments...
Redirecting to https://www.labroots.com/login Redirecting to https://www.labroots.com/login.
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds